The drug is transferred to the Estonian Embassy in Tokyo.
Estonia will receive the first from Japan to be a potential cure against COVID-19 for research and potential use in the treatment of coronavirus.
The drug Avigan, passed the Estonian Embassy in Tokyo and will be delivered to Estonia next week, according to nv.ua.
“The fact that Estonia will receive from the Japanese drug Avigan, is a very good example of international cooperation in a crisis situation. I spoke Thursday with his Japanese counterpart Toshimitsu Motegi and thanked him,” said Estonian foreign Minister Urmas Reinsalu.
The drug Avigan, which will receive Estonia, developed by Japanese pharmaceutical company Toyama Chemicals, Fujifilm as a remedy against influenza.
More than 80 countries had submitted their applications to receive medication for testing and experimental use in COVID-19. Japan free allocated drug for research in the fight against the pandemic coronavirus.
At the same time, Estonia will have to share the results of clinical trials.
Scientists from different countries continue to search for an effective vaccine against the coronavirus. Italian researchers plan to begin testing on humans of a vaccine of its own design in the fall.
Some progress in the field of antibodies to the coronavirus SARS-CoV-2 was reached by the researchers from Israel.
Another promising development is the vaccine, which is created in a pharmaceutical laboratory of the University of San Diego in the United States. Scientists use the DNA of the coronavirus together with fragments of other viruses, which are safe for humans.